clarithromycin has been researched along with Haemophilus Infections in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.56) | 18.7374 |
1990's | 11 (28.21) | 18.2507 |
2000's | 10 (25.64) | 29.6817 |
2010's | 14 (35.90) | 24.3611 |
2020's | 3 (7.69) | 2.80 |
Authors | Studies |
---|---|
Agouridas, C; Auger, JM; Benedetti, Y; Bonnefoy, A; Bretin, F; Chantot, JF; D'Ambrières, SG; Denis, A; Dussarat, A; Fromentin, C; Lachaud, S; Laurin, P; Le Martret, O; Loyau, V; Tessot, N | 1 |
Anderson, S; Barker, L; Burger, MT; Carroll, GL; Chu, DT; Desai, MC; Hiebert, C; Huh, K; Kidney, J; Langhorne, M; Lin, X; Plattner, JJ; Rico, AC; Seid, M; Shawar, R; Young, K | 1 |
Ki, CS; Kim, IS; Kim, S; Lee, K; Lee, NY; Oh, WS; Peck, KR; Song, JH | 1 |
Bae, S; Kang, Y; Kim, E; Lee, J; Lee, S; Yu, J | 1 |
Araki, N; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Nakamura, S; Seki, M; Yamada, K; Yamamoto, Y; Yanagihara, K | 1 |
Kaneda, Y; Manaka, A; Nanaumi, K; Shimazaki, Y; Sugimoto, T; Sugiyama, H; Suzuki, K; Tanikawa, T; Yamasaki, Y | 1 |
Noguchi, N; Saito, M; Seyama, S; Tanaka, E; Wajima, T; Yamada, S; Yuzawa, Y | 1 |
Gibson, PG; Ivey, KL; Rogers, GB; Simpson, JL; Taylor, SL | 1 |
Imuta, N; Iuchi, H; Kiyama, S; Kurono, Y; Nishi, J; Ohori, J; Yamashita, M | 1 |
Ando, M; Hirano, T; Kadota, JI; Ono, T; Tokimatsu, I; Usagawa, Y; Yoshikawa, H | 1 |
Keng, LT; Lee, MR | 1 |
Iino, Y; Kakizaki, K; Kakuta, H; Kato, T; Miyazawa, T; Yoshida, N | 1 |
Beckett, EL; Essilfie, AT; Foster, PS; Gibson, PG; Hansbro, PM; Horvat, JC; Kim, RY; Mayall, JR; Pinkerton, JW; Simpson, JL; Starkey, MR | 1 |
Brusselle, GG | 1 |
Shimizu, T; Suzaki, H | 1 |
Dang, V; Deeks, SL; Desai, S; Fediurek, J; Jamieson, FB; Navaranjan, D; Patel, SN; Seo, CY | 1 |
Fujii, T; Noguchi, N; Seyama, S; Suzuki, M; Ushio, M; Wajima, T | 1 |
Lin, CM; Liu, YC; Wang, CW | 1 |
Araki, N; Kamihira, S; Kohno, S; Morinaga, Y; Nakamura, S; Yamada, K; Yamada, Y; Yanagihara, K | 1 |
Kubo, K; Tanabe, T; Ushiki, A; Yamazaki, Y | 1 |
Alihodžić, S; Bencetić Mihaljević, V; Bosnar, M; Bošnjak, B; Brajša, K; Culić, O; Eraković Haber, V; Glojnarić, I; Hrvačić, B; Jelić, D; Kapić, S; Koštrun, S; Kragol, G; Marušić Ištuk, Z; Padovan, J; Spaventi, R; Tavčar, B; Verbanac, D; Vujasinović, I | 1 |
Appelbaum, PC; Bozdogan, B; Jacobs, MR; Peric, M | 1 |
Appelbaum, PC; Bogdanovich, T; Bozdogan, B | 1 |
Anzueto, A; Choudhri, S; Haverstock, D; Kureishi, A; Niederman, MS; Perroncel, R; Sethi, S | 1 |
De Vecchi, E; Drago, L; Larosa, M; Nicola, L | 1 |
Carpentier, M; Delmée, M; Glupczynski, Y; Gordts, B; Magerman, K; Simon, A; Surmont, I; Van de Vyvere, M; Van Landuyt, H; Van Nimmen, L; Van Noyen, R | 1 |
McLinn, S; Williams, D | 1 |
Klein, JO | 1 |
Nightingale, CH | 1 |
Block, SL | 1 |
Alder, JD; Ewing, PJ; Jarvis, K; Mitten, M; Nilius, AM; Oleksijew, A; Paige, L; Tanaka, SK; Tovcimak, A | 1 |
Hill, SL; Johnson, MM; Piddock, LJ | 1 |
Arnold, J; Cockburn, J; Emmanuel, FX; Paton, R | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Fujikawa, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
Chen, HY; Maskell, JP; Powell, M | 1 |
Azoulay-Dupuis, E; Bergogne-Bérézin, E; Pocidalo, JJ; Swanson, R; Vallée, E | 1 |
Clement, JJ; Hardy, DJ; Marsh, K; Rode, RA; Shipkowitz, NL; Swanson, RN | 1 |
Bailer, R; Fernandes, PB; Gade, E; Hardy, D; McDonald, E; Pintar, J; Ramer, N; Swanson, R | 1 |
5 review(s) available for clarithromycin and Haemophilus Infections
Article | Year |
---|---|
Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; Haemophilus Infections; History, 20th Century; History, 21st Century; Humans; Japan; Macrolides; Nasal Polyps; Rhinitis; Sinusitis | 2016 |
Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bronchitis, Chronic; Chronic Disease; Clarithromycin; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Moxifloxacin; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
History of macrolide use in pediatrics.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Interactions; Erythromycin; Haemophilus Infections; Haemophilus influenzae; History, 20th Century; Humans; Infant; Infant, Newborn; Microscopy, Electron; Phagocytes; Phagocytosis | 1997 |
Pharmacokinetics and pharmacodynamics of newer macrolides.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Ear, Middle; Haemophilus Infections; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Streptococcal Infections; Tissue Distribution | 1997 |
Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactam Resistance; Child; Child, Preschool; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Moraxella catarrhalis; Neisseriaceae Infections; Otitis Media; Penicillin Resistance; Penicillins; Streptococcal Infections; Streptococcus pneumoniae | 1997 |
1 trial(s) available for clarithromycin and Haemophilus Infections
Article | Year |
---|---|
Clinical effects of clarithromycin on persistent inflammation following Haemophilus influenzae-positive acute otitis media.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Carbocysteine; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Otitis Media; Treatment Failure | 2015 |
33 other study(ies) available for clarithromycin and Haemophilus Infections
Article | Year |
---|---|
Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Crystallography, X-Ray; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Ketolides; Macrolides; Male; Mice; Models, Molecular; Molecular Conformation; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcus; Streptococcus pneumoniae | 1998 |
Synthesis and antibacterial activity of novel C12 vinyl ketolides.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Enterococcus faecalis; Haemophilus Infections; Haemophilus influenzae; Half-Life; Ketolides; Lung Diseases; Male; Microbial Sensitivity Tests; Pneumococcal Infections; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Vinyl Compounds | 2006 |
Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea.
Topics: Ampicillin Resistance; beta-Lactamases; Drug Resistance, Bacterial; Genes, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Korea; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Species Specificity | 2007 |
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Ampicillin Resistance; beta-Lactamases; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Penicillin-Binding Proteins; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Serotyping; Young Adult | 2010 |
Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice.
Topics: Animals; Anti-Bacterial Agents; Bronchioles; Bronchoalveolar Lavage Fluid; Cell Line, Tumor; Chemokine CXCL2; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Enzyme-Linked Immunosorbent Assay; Haemophilus Infections; Haemophilus influenzae; Humans; Interleukin-1beta; Male; Mice; Microbial Sensitivity Tests; Neutrophils; Pneumonia; Pulmonary Alveoli | 2010 |
Synthesis and antibacterial activity of 6-O-(heteroaryl-isoxazolyl)propynyl 2-fluoro ketolides.
Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Drug Resistance, Bacterial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Halogenation; Humans; Ketolides; Microbial Sensitivity Tests; Models, Molecular; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus | 2012 |
β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Clarithromycin; Drug Resistance, Multiple, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Sequence Analysis, DNA | 2020 |
Airway abundance of
Topics: Adult; Anti-Bacterial Agents; Asthma; Azithromycin; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 2020 |
Effectiveness of antibacterial agents against cell-invading bacteria such as Streptococcus pyogenes and Haemophilus influenzae.
Topics: Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Streptococcal Infections; Streptococcus pyogenes | 2021 |
The development of diffuse panbronchiolitis during the treatment with long-term, low-dose clarithromycin for chronic sinusitis.
Topics: Adult; Anti-Bacterial Agents; Bronchiolitis; Chronic Disease; Clarithromycin; Haemophilus Infections; Humans; Male; Sinusitis | 2019 |
Diffuse panbronchiolitis.
Topics: Anti-Bacterial Agents; Bronchiolitis; Clarithromycin; Diagnosis, Differential; Haemophilus Infections; Humans; Male; Middle Aged; Tomography, X-Ray Computed | 2019 |
Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Asthma; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Dexamethasone; Disease Models, Animal; Female; Glucocorticoids; Haemophilus Infections; Haemophilus influenzae; Mice; Mice, Inbred BALB C | 2015 |
Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Asthma; Azithromycin; Bronchiolitis Obliterans; Chlamydophila Infections; Clarithromycin; Female; Haemophilus Infections; Humans; Lung Transplantation; Male | 2015 |
The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae type b; Haemophilus Vaccines; Humans; Incidence; Infant; Infant, Newborn; Inhibitory Concentration 50; Male; Middle Aged; Ontario; Poisson Distribution; Serogroup; Serotyping; Young Adult | 2015 |
Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A).
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests | 2017 |
Is ionizing radiation a risk factor to diffuse panbronchiolitis?
Topics: Alpha Particles; Bronchiolitis; Clarithromycin; Haemophilus Infections; Humans; Male; Middle Aged; Nuclear Power Plants; Occupational Diseases; Radiation Injuries; Risk Factors; Tomography, X-Ray Computed | 2017 |
Azithromycin inhibits nontypeable Haemophilus influenzae-induced MUC5AC expression and secretion via inhibition of activator protein-1 in human airway epithelial cells.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line, Tumor; Clarithromycin; Epithelial Cells; Haemophilus Infections; Haemophilus influenzae; Humans; Mucin 5AC; RNA, Messenger; Transcription Factor AP-1 | 2010 |
[Anti-bacterial and anti-inflammatory actions of clarithromycin against Haemophilus influenzae that has infiltrated the respiratory epithelial cells].
Topics: Cells, Cultured; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; RNA, Messenger | 2009 |
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Bronchiolitis; Bronchoalveolar Lavage Fluid; Cell Line; Clarithromycin; Cystic Fibrosis; Drug Interactions; Drug Resistance, Bacterial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Interleukin-6; Lipopolysaccharides; Lung; Macrolides; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moraxella catarrhalis; Neutrophils; Rats; Rats, Sprague-Dawley; Streptococcus | 2012 |
Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Genes, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mutation; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Ribosomes | 2003 |
Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Haemophilus Infections; Haemophilus influenzae; Ketolides; Macrolides; Microbial Sensitivity Tests; Time Factors | 2006 |
In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Carbon Dioxide; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Time Factors | 2008 |
In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefotaxime; Cefuroxime; Child; Child, Preschool; Clarithromycin; Clavulanic Acids; Cross Infection; Haemophilus Infections; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Middle Aged | 1996 |
Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Child; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Incidence; Microbial Sensitivity Tests; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 1996 |
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; Lung Diseases; Rats; Rats, Sprague-Dawley | 1998 |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents.
Topics: Anti-Bacterial Agents; Azithromycin; Carbon Dioxide; Clarithromycin; Colony Count, Microbial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Hydrogen-Ion Concentration; Lung Diseases, Obstructive; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Sputum; Streptococcus pneumoniae | 1999 |
Susceptibility testing of Haemophilus influenzae to clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 2000 |
Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Culture Media; Haemophilus Infections; Haemophilus influenzae; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Quality Control | 2001 |
Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Bronchopneumonia; Clarithromycin; Disease Models, Animal; Haemophilus Infections; Haemophilus influenzae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Treatment Outcome | 2001 |
Protective efficacy of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae in a murine septicaemia model.
Topics: Animals; Bacteremia; Clarithromycin; Disease Models, Animal; Drug Synergism; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Mice; Mice, Inbred BALB C | 1992 |
Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Lung Diseases; Mice; Mice, Inbred C57BL | 1991 |
Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.
Topics: Animals; Clarithromycin; Drug Synergism; Erythromycin; Female; Gerbillinae; Haemophilus Infections; Haemophilus influenzae; Microbial Sensitivity Tests; Otitis Media | 1990 |
Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Culture Media; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Kinetics; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Sepsis | 1987 |